BAY 2433334
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BAY 2433334, covering 2022-10-27 to 2023-04-19. Get the full timeline:
Most recent: Clinical Trial Update: Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain. [Phase 2]